These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 26497793)

  • 1. MicroRNA target prediction in glaucoma.
    Romano GL; Platania CB; Forte S; Salomone S; Drago F; Bucolo C
    Prog Brain Res; 2015; 220():217-40. PubMed ID: 26497793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retinal and Circulating miRNAs in Age-Related Macular Degeneration: An
    Romano GL; Platania CBM; Drago F; Salomone S; Ragusa M; Barbagallo C; Di Pietro C; Purrello M; Reibaldi M; Avitabile T; Longo A; Bucolo C
    Front Pharmacol; 2017; 8():168. PubMed ID: 28424619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Up-regulated Pro-inflammatory MicroRNAs (miRNAs) in Alzheimer's disease (AD) and Age-Related Macular Degeneration (AMD).
    Pogue AI; Lukiw WJ
    Cell Mol Neurobiol; 2018 Jul; 38(5):1021-1031. PubMed ID: 29302837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Deregulated MicroRNAs in Age-Related Macular Degeneration Pathology.
    ElShelmani H; Wride MA; Saad T; Rani S; Kelly DJ; Keegan D
    Transl Vis Sci Technol; 2021 Feb; 10(2):12. PubMed ID: 34003896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA expression analysis of adult-onset Drosophila Alzheimer's disease model.
    Kong Y; Wu J; Yuan L
    Curr Alzheimer Res; 2014; 11(9):882-91. PubMed ID: 25274109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deregulation of miRNA-181c potentially contributes to the pathogenesis of AD by targeting collapsin response mediator protein 2 in mice.
    Zhou H; Zhang R; Lu K; Yu W; Xie B; Cui D; Jiang L; Zhang Q; Xu S
    J Neurol Sci; 2016 Aug; 367():3-10. PubMed ID: 27423553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shared miRNA landscapes of COVID-19 and neurodegeneration confirm neuroinflammation as an important overlapping feature.
    Redenšek Trampuž S; Vogrinc D; Goričar K; Dolžan V
    Front Mol Neurosci; 2023; 16():1123955. PubMed ID: 37008787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. microRNA dysregulation in neurodegenerative diseases: A systematic review.
    Juźwik CA; S Drake S; Zhang Y; Paradis-Isler N; Sylvester A; Amar-Zifkin A; Douglas C; Morquette B; Moore CS; Fournier AE
    Prog Neurobiol; 2019 Nov; 182():101664. PubMed ID: 31356849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening of microRNAs associated with Alzheimer's disease using oxidative stress cell model and different strains of senescence accelerated mice.
    Zhang R; Zhang Q; Niu J; Lu K; Xie B; Cui D; Xu S
    J Neurol Sci; 2014 Mar; 338(1-2):57-64. PubMed ID: 24423585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating miRNAs as Potential Biomarkers of Age-Related Macular Degeneration.
    Ren C; Liu Q; Wei Q; Cai W; He M; Du Y; Xu D; Wu Y; Yu J
    Cell Physiol Biochem; 2017; 41(4):1413-1423. PubMed ID: 28315863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNAs in glaucoma and neurodegenerative diseases.
    Molasy M; Walczak A; Szaflik J; Szaflik JP; Majsterek I
    J Hum Genet; 2017 Jan; 62(1):105-112. PubMed ID: 27412874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant microRNA expression in the brains of neurodegenerative diseases: miR-29a decreased in Alzheimer disease brains targets neurone navigator 3.
    Shioya M; Obayashi S; Tabunoki H; Arima K; Saito Y; Ishida T; Satoh J
    Neuropathol Appl Neurobiol; 2010 Jun; 36(4):320-30. PubMed ID: 20202123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-Target Interaction Regulatory Network in Alzheimer's Disease.
    Turk A; Kunej T; Peterlin B
    J Pers Med; 2021 Dec; 11(12):. PubMed ID: 34945753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific Signatures of Serum miRNAs as Potential Biomarkers to Discriminate Clinically Similar Neurodegenerative and Vascular-Related Diseases.
    Barbagallo C; Mostile G; Baglieri G; Giunta F; Luca A; Raciti L; Zappia M; Purrello M; Ragusa M; Nicoletti A
    Cell Mol Neurobiol; 2020 May; 40(4):531-546. PubMed ID: 31691877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery and validation of extracellular/circulating microRNAs during idiopathic pulmonary fibrosis disease progression.
    Yang G; Yang L; Wang W; Wang J; Wang J; Xu Z
    Gene; 2015 May; 562(1):138-44. PubMed ID: 25725128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deregulated microRNAs in triple-negative breast cancer revealed by deep sequencing.
    Chang YY; Kuo WH; Hung JH; Lee CY; Lee YH; Chang YC; Lin WC; Shen CY; Huang CS; Hsieh FJ; Lai LC; Tsai MH; Chang KJ; Chuang EY
    Mol Cancer; 2015 Feb; 14():36. PubMed ID: 25888956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A complex crosstalk between polymorphic microRNA target sites and AD prognosis.
    Mallick B; Ghosh Z
    RNA Biol; 2011; 8(4):665-73. PubMed ID: 21659796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA as Therapeutics for Age-Related Macular Degeneration.
    Natoli R; Fernando N
    Adv Exp Med Biol; 2018; 1074():37-43. PubMed ID: 29721925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-34a is an intracellular and exosomal predictive biomarker for response to docetaxel with clinical relevance to prostate cancer progression.
    Corcoran C; Rani S; O'Driscoll L
    Prostate; 2014 Sep; 74(13):1320-34. PubMed ID: 25053345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating miR-125b as a biomarker of Alzheimer's disease.
    Tan L; Yu JT; Liu QY; Tan MS; Zhang W; Hu N; Wang YL; Sun L; Jiang T; Tan L
    J Neurol Sci; 2014 Jan; 336(1-2):52-6. PubMed ID: 24139697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.